NVNO
$11.56-0.23 (-1.95%)
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.
Recent News
Insider Buyers Lose Additional US$294k As enVVeno Medical Dips To US$6.5m
The recent price decline of 22% in enVVeno Medical Corporation's ( NASDAQ:NVNO ) stock may have disappointed insiders...
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve
enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure.
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index and the Health Car
EnVVeno Medical Gets FDA Not-Approvable Letter for VenoValve; Shares Fall 70%
EnVVeno Medical (NVNO) shares were down 70% in recent Wednesday trading after the company said it re
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...